Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9977 |
SGK1-IN-4
|
SGK | Metabolism |
SGK1-IN-4 是 SGK1 的特异性抑制剂,可用于骨关节炎研究。 | |||
T13847 |
PROTAC SGK3 degrader-1
SGK3-PROTAC1 |
SGK | Metabolism |
PROTAC SGK3 degrader-1 (SGK3-PROTAC1) 是一种靶向 SGK3 且与 VH032 VHL 结合配体的 PROTAC 偶联物,可诱导内源性 SGK3 降解。PROTAC SGK3 degrader-1 可抑制GDC0941诱导的癌细胞增殖。 | |||
T6635 |
EMD638683
|
SGK | Metabolism |
EMD638683 是一种具有抗高血压效力的新型 SGK 抑制剂,IC50=3 μM。 | |||
T2622 |
GSK 650394
GSK650394 |
SGK; Influenza Virus | Metabolism; Microbiology/Virology |
GSK 650394 是一种新颖的 SGK 抑制剂,可抑制流感病毒复制。它还是一种血清和糖皮质激素调节的激酶 1 抑制剂。 | |||
T12890 | SGK1-IN-1 | Others | Others |
SGK1-IN-1 is a highly active and selective SGK-1 inhibitor(IC50 of 1 nM). | |||
T12891 | SGK1-IN-2 | Others | Others |
SGK1-IN-2 (14h) is a selective inhibitor of SGK1 (serum and glucocorticoid regulated kinase 1)(with an IC50 of 5 nM at 10 μM ATP concentration). | |||
T63741 | SGK1-IN-3 | ||
SGK1-IN-3 是有效的、口服具有活力的 SGK1 抑制剂。其中丝氨酸/苏氨酸激酶 SGK1 是 β-连环蛋白途径的激活剂,也是强大的软骨降解刺激剂,在患病的骨关节炎软骨中被发现在基因组控制下被上调。SGK1-IN-3 对骨关节炎表现出研究潜力。 | |||
T71947 |
SGK1 inhibitor
|
||
SGK1 inhibitor is an inhibitor of serum- and glucocorticoid-regulated kinase 1 (SGK1) and SGK2. It is selective for SGK1 and SGK2 over SGK3 in the presence of a high concentration of ATP. SGK1 inhibitor prevents phosphorylation of GSK3β in U2OS cells and decreases cell viability in BYL719-insensitive HCC1954 cells when used in combination with the PI3Kα inhibitor BYL719. SGK1 inhibitor reduces tumor growth in an HCC1954 mouse xenograft model when administered in combination with BYL719. | |||
T19913 |
CKI-7
CKI 7 2HCl,CKI-7 dihydrochloride,N-(2-氨基乙基)-5-氯异喹啉-8-磺酰胺二盐酸盐,CKI7 2HCl,CKI 7 dihydrochloride,CKI7 dihydrochloride,CKI-7 2HCl |
ROCK; SGK; Casein Kinase; CDK; S6 Kinase | Cell Cycle/Checkpoint; Cytoskeletal Signaling; MAPK; Metabolism; PI3K/Akt/mTOR signaling; Stem Cells |
CKI-7 是一种有效且 ATP 竞争性的酪蛋白激酶 1 抑制剂,IC50为 6 μM,Ki 为 8.5 μM。它选择性抑制 Cdc7激酶,还抑制 SGK,S6K1以及 MSK1。 | |||
T10829 |
CKI-7 free base
CKI-7 |
Casein Kinase | Metabolism; Stem Cells |
CKI-7 free base is a potent and ATP-competitive inhibitor of casein kinase 1 (CK1; IC50: 6 μM; Ki: 8.5 μM) and a selective Cdc7 kinase inhibitor. CKI-7 free base also inhibits SGK, ribosomal S6 kinase-1 (S6K1), and MSK1. | |||
T73247 | PIM1-IN-4 | Pim | Chromatin/Epigenetic; JAK/STAT signaling |
PIM1-IN-4(Compound 8)为PIM1高效抑制剂,对SGK-1、PKA、CaMK-1、GSK3β及MSK1五种酶亦展现出显著抑制效应,表现出其在癌症疾病研究中的应用潜力。 | |||
T10275 |
AKT-IN-3
|
Akt | Cytoskeletal Signaling; PI3K/Akt/mTOR signaling |
AKT-IN-3 is a potent, orally active low hERG blocking Akt inhibitor (IC50: 1.4 nM, 1.2 nM, and 1.7 nM for Akt1, Akt2, and Akt3). AKT-IN-3 (compound E22) also exhibits good inhibitory activity against other AGC family kinases, such as PKA, PKC, ROCK1, RSK1 | |||
T2356 |
Ro-3306
|
Apoptosis; ERK; SGK; PKA; CDK; PKC | Apoptosis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; MAPK; Metabolism; Tyrosine Kinase/Adaptors |
Ro 3306 是一种选择性 ATP 竞争性CDK1抑制剂,对 CDK1、CDK1/cyclin B1 和 CDK2/cyclin E 的Ki 值为分别为 20 nM、35 nM 和 340 nM。 | |||
T14779 |
BRD7389
|
SGK; FLT; Pim; CDK; S6 Kinase; DAPK | Angiogenesis; Apoptosis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; JAK/STAT signaling; MAPK; Metabolism; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors |
BRD7389 是一种 RSK 家族激酶抑制剂,对 RSK1、RSK2 和 RSK3 的 IC50 分别为 1.5 μM、2.4 μM 和 1.2 μM。 |